—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bausch Health Companies Inc (BHC.TO) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for BHC.TO, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Drug Manufacturers - Specialty & Generic · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BHC.TO on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Bausch Health Companies Inc

BHC.TO in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bausch Health is a diversified specialty pharmaceutical and medical device company operating through five segments: Salix, International, Solta Medical, Diversified and Bausch + Lomb. It develops and sells products across gastroenterology, hepatology, neurology, dermatology, generics, dentistry, over-the-counter care, aesthetic devices and eye health, across many countries. It is headquartered in Laval, Canada, and was formerly known as Valeant Pharmaceuticals International.
Where it sits in the stack
Bausch Health carries no seat in our index, so it sits within our broader healthcare universe, in the specialty and generic drugmakers sleeve rather than the AI build-out stack. Its business runs on prescription and device sales rather than compute infrastructure, so it stands outside the layers our diary tracks for chip and data-centre demand.
Who it is priced against
Bausch Health is best read against other specialty and generic drugmakers with multiple therapeutic lines, a group that includes Teva Pharmaceutical as a name the market often names alongside it.
Why Closelooknet tracks it
Bausch Health holds no seat in our index and carries no score yet, so the diary follows it only through its own chart readings rather than through index quotes.
What the diary watches
Whether the shares extend their move further below both the 50-day and 200-day averages, since they already sit under each and well off their 52-week high.

Bausch Health Companies Inc (BHC.TO) trades on the TO exchange in Canada.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Bausch Health Companies Inc (BHC.TO)?

Bausch Health Companies Inc trades as BHC.TO on the TO exchange (Canada) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is BHC.TO in a Closelooknet index?

Not currently — Bausch Health Companies Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does BHC.TO trade against its moving averages?

Bullish stack, 200-day still turning: Trades +0.6% vs the 50-day and +7.3% vs the 200-day average, 22.7% below the 52-week high and +40.3% off the 52-week low; a golden cross printed 15 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Bausch Health Companies Inc compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic), Bausch Health Companies Inc (BHC.TO) sits 22.7% below its 52-week high, 0.6% above its 50-day average; Laboratorios Farmaceuticos ROVI (ROVI.MC) is 31.8% below, Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 4.2% below, Almirall S.A. (ALM.MC) is 26.2% below. Put any of them next to BHC.TO in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Bausch Health Companies Inc do?

Bausch Health is a diversified specialty pharmaceutical and medical device company operating through five segments: Salix, International, Solta Medical, Diversified and Bausch + Lomb. It develops and sells products across gastroenterology, hepatology, neurology, dermatology, generics, dentistry, over-the-counter care, aesthetic devices and eye health, across many countries. It is headquartered in Laval, Canada, and was formerly known as Valeant Pharmaceuticals International. Bausch Health is best read against other specialty and generic drugmakers with multiple therapeutic lines, a group that includes Teva Pharmaceutical as a name the market often names alongside it.

Where does Bausch Health Companies Inc sit in the AI build-out?

Bausch Health carries no seat in our index, so it sits within our broader healthcare universe, in the specialty and generic drugmakers sleeve rather than the AI build-out stack. Its business runs on prescription and device sales rather than compute infrastructure, so it stands outside the layers our diary tracks for chip and data-centre demand. Bausch Health holds no seat in our index and carries no score yet, so the diary follows it only through its own chart readings rather than through index quotes.

What does this page show?

A live price chart with SMA overlays and drawing tools for BHC.TO, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.